Literature DB >> 6873581

[Recurrence and prevention of recurrence after dissolution of gallbladder lithiasis by chenodeoxycholic acid in 22 patients].

J Toulet, J Rousselet, J M Viteau, Y Duchon, R Pagniez, B Samain, J L Vienne.   

Abstract

Dissolution of gallstones was observed 33 times in 22 patients. For 11 of them a recurrent lithiasis was dissolved by means of a second or third medical treatment. 21 patients have been followed for 3 to 6 years (median over 4 years). Without longstanding treatment the recurrence rate was 50 p. 100 in 3 years and 87.5 p. 100 in 6 years. Most of the patients should have relapsed in less than 9 years. Recurrences were always successfully treated with the same treatment but relapsed if the treatment was stopped (21 recurrences in 14 patients). A-1 month every 4 months-long standing treatment did not prevent recurrences in 8 patients whereas treatment every other month prevented recurrences in 5. It is therefore suggested to give long treatment after dissolution of gallstones to avoid recurrences. Its duration should be undefinite. Alternatives might include: 1) repeated dissolving treatments in case of recurrences, if relapses occur lately; 2) or longstanding treatment in case of early recurrences.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873581

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  6 in total

1.  Progress in gall stone disease.

Authors:  M C Bateson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-03

Review 2.  A practical guide to the nonsurgical treatment of gallstones.

Authors:  D P Maudgal; T C Northfield
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

3.  Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.

Authors:  M Boscaini; M Piccinni-Leopardi; F Andreotti; A Montori
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

4.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

5.  Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.

Authors:  K von Bergmann; A Beck; C Engel; O Leiss
Journal:  Klin Wochenschr       Date:  1987-05-15

6.  Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.

Authors:  D C Ruppin; G M Murphy; R H Dowling
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.